Alternatives to TeraCyte

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Cloud-based platform for reproducible computational research in life sciences.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Israel's leading bio-foundry for synthetic biology innovation, spanning ideation to proof-of-concept.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Compressing biology to develop the next generation of therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

AI-powered insights platform for life sciences and biotech workflows.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

EU-based company providing personalized medicine solutions for medical practitioners.

DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.

AI-powered platform for designing novel molecular structures for new medicines.

Life science company pioneering drug discovery with AI and advanced technologies.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Unleashing the power of genomics at scale for biological advances and human health.

AI-driven digital twin of embryo development for cell-based therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Developing novel therapeutics for rare genetic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Advanced infectious disease diagnostics

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

AI-powered platform accelerating biological research and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Stealth mode startup in life sciences and synthetic biology.